Anti-Angiogenic Activity of Drugs in Multiple Myeloma

SIMPLE SUMMARY: The “angiogenic switch” contributes to the transition from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM), sustaining disease progression and drug resistance. In this review, we describe the anti-angiogenic activity of drugs employed in clinical se...

Descripción completa

Detalles Bibliográficos
Autores principales: Saltarella, Ilaria, Altamura, Concetta, Campanale, Carmen, Laghetti, Paola, Vacca, Angelo, Frassanito, Maria Antonia, Desaphy, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093708/
https://www.ncbi.nlm.nih.gov/pubmed/37046651
http://dx.doi.org/10.3390/cancers15071990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093708/
https://www.ncbi.nlm.nih.gov/pubmed/37046651
http://dx.doi.org/10.3390/cancers15071990

Ejemplares similares